← Leaderboards
Stephen Douglas Barrett
Cayman Chemical Company, Inc.
$1,478,369
Attributed
$1,478,369
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $750.1K · FY2019–20$1M$750K$500K$250K$0
'19
'20
Funding mix
By agency
NIH$1,478,369 · 1
By mechanism
R44$1,478,369 · 1
Top collaborators
No co-investigators on record.
Most similar at Cayman Chemical Company, Inc.
Same institution · by research overlap
- Thomas A Owen$850,243
- Daniel Bochar$224,852
- Paul Douglas Kennedy$306,868
Others in their field
Other Emerging Leaders on “Aged”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$64,693,871
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,272,240
- Abraham Aizer Brody · New York University School Of Medicine$23,963,022
Research focus
AgedAgingAging PopulationAgonistBaseBody WeightBoneBone RegenerationCaymansCellsClinical PathologyClinical ResearchCollagenCyclic GmpDefectDesignDevicesDoseEconomic BurdenEconomicsEfficacy StudyElderlyEp4 ReceptorAccounting